Why Tilray Stock Soared 27.5% Today

President Trump said his administration is actively considering reclassifying marijuana to a lower federal schedule — a move that would materially reduce cannabis companies’ tax burden and mark a significant step toward full federal legalization — and Tilray Brands shares jumped 27.5% on the news. While the announcement boosts sector sentiment and makes regulatory progress more plausible given bipartisan support, Tilray’s underlying financials remain challenged despite recent cost cuts, so upside depends on whether legal changes materialize and how quickly they translate into improved margins and access to capital.

Analysis

President Trump confirmed from the Oval Office that his administration is actively considering reclassifying cannabis to Schedule III — saying "a lot of people want to see it" — and the article notes that such reclassification would materially reduce the tax burden on cannabis companies and represent a substantive step toward federal legalization. The move is characterized as politically plausible because it has substantial bipartisan support, which increases the probability of at least an administrative reclassification versus no policy action.

Market reaction was immediate and concentrated: Tilray Brands (TLRY) shares jumped 27.5% on the announcement while the S&P 500 fell 0.3% and the Nasdaq Composite rose 0.2%, consistent with the provided moderately positive sentiment and a market impact score of 0.6; per-ticker sentiment for TLRY is notably higher at 0.7, indicating outsized investor enthusiasm. This is a headline-driven, idiosyncratic rally rather than evidence of near-term fundamental improvement.

Tilray's underlying financials are described as weak despite recent operating-cost reductions, and the Motley Fool team did not include TLRY among its top 10 stock picks; the publication frames ownership as appropriate only for investors with high risk tolerance and a long time horizon. The investment case hinges on regulatory follow-through and the speed with which tax relief would translate into improved margins and access to capital, so outcomes remain binary and contingent on future official actions.

Key Decisions for Investors

• Consider trimming or taking partial profits on short-term positions after the 27.5% pop since the move appears headline-driven and could reverse if no formal action follows
• For long-term, risk-tolerant investors, a small, size-controlled position in Tilray can be considered as a high-beta, asymmetric bet on reclassification, but cap exposure given weak fundamentals
• Monitor concrete catalysts closely — DOJ/DEA scheduling announcements, regulatory guidance, and any legislative activity — and only increase exposure after clear policy change or demonstrable margin/capital-access improvements
• Employ strict risk management (position limits or protective options) because upside is contingent on regulatory outcomes and downside remains substantial if reclassification stalls